DAFNA Capital Management’s Novavax NVAX Stock Holding History

DAFNA Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-35,000	Closed	-$1.32M	–	84
2018 Q3	$1.32M	Sell	35,000 -2,500	-7%	-$70.4K	0.54%	47
2018 Q2	$1M	Buy	+37,500	New	+$1.27M	0.47%	52
2016 Q3	–	Sell	-27,500	Closed	-$4M	–	90
2016 Q2	$4M	Sell	27,500 -175	-0.6%	-$20.1K	3.17%	8
2016 Q1	$2.86M	Buy	+27,675	New	+$2.97M	2.46%	11
2013 Q4	–	Sell	-10,500	Closed	-$662K	–	48
2013 Q3	$662K	Buy	+10,500	New	+$591K	0.72%	37

Other funds holding NVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

DAFNA Capital Management's NVAX Position: Q4 2018 in Review

DAFNA Capital Management sold out of Novavax (NVAX) in Q4 2018, closing a stake of 35,000 shares — an estimated $1.32M sold.

DAFNA Capital Management first reported a position in NVAX in Q3 2013 and held it in 5 quarters. The position peaked at $4M in Q2 2016. 168 funds tracked by Wall St. Rank hold NVAX as of Q4 2018.

DAFNA Capital Management reported no remaining Novavax position as of Q4 2018 after selling out during the quarter.
DAFNA Capital Management sold 35,000 Novavax shares in Q4 2018, an estimated $1.32M.
DAFNA Capital Management first reported a position in Novavax in Q3 2013 and held it in 5 quarters.
DAFNA Capital Management's Novavax position peaked at $4M in Q2 2016.
168 funds tracked by Wall St. Rank held Novavax as of Q4 2018.

Based on DAFNA Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.